Skip to content

800.850.4306

  • Insights
    • News
    • Media
    • Events
  • About Us
    • Who We Are
    • Careers
  • Contact
  • Insights
    • News
    • Media
    • Events
  • About Us
    • Who We Are
    • Careers
  • Contact
  • Patients
    • Rare and Orphan Care
  • Providers
    • Risk-Based Care
    • Financial Assistance
    • Rare and Orphan Care
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
  • Payers
  • How to Prescribe
  • Patients
    • Rare and Orphan Care
  • Providers
    • Risk-Based Care
    • Financial Assistance
    • Rare and Orphan Care
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
  • Payers
  • How to Prescribe

Month: August 2020

INQOVI (cedazuridine and decitabine), FDA Approved for Treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Available at Biologics by McKesson

CARY, N.C., August 21, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

11800 Weston Parkway
Cary, NC 27513
T. 800.850.4306

Legal

  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice
  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice

For Patients

  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)
  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)

Learn more about McKesson

  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe
  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe

© 2024 McKesson Corporation. All Rights Reserved.